Arief Nurrochmad

Dr. Arief Nurrochmad

Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Life
Verified
Journal Article
Open access
PDF file
IPI Made Wisnu Adhi Putra
I Made Wisnu Adhi Putra
NFNanang Fakhrudin
Nanang Fakhrudin
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
SWSubagus Wahyuono
Subagus Wahyuono
Diabetic nephropathy (DN), also recognized as diabetic kidney disease, is a kidney malfunction caused by diabetes mellitus. A possible contributing factor to the onset of DN is hyperglycemia. Poorly regulated hyperglycemia can damage blood vessel clusters in the kidneys, leading to kidney damage. Its treatment is difficult and expensive because its causes are extremely complex and poorly understood. Extracts from medicinal plants can be an alternative treatment for DN. The bioactive content in medicinal plants inhibits the progression of DN. This work explores the renoprotective activity and possible mechanisms of various medicinal plant extracts administered to diabetic animal models. Research articles published from 2011 to 2022 were gathered from several databases including PubMed, Scopus, ProQuest, and ScienceDirect to ensure up-to-date findings. Results showed that medicinal plant extracts ameliorated the progression of DN via the reduction in oxidative stress and suppression of inflammation, advanced glycation end-product formation, cell apoptosis, and tissue injury-related protein expression.

1 April 2009 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
STShuso Takeda
Shuso Takeda
YIYuji Ishii
Yuji Ishii
MIMegumi Iwanaga
Megumi Iwanaga
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
YIYuji Ito
Yuji Ito
HYHideyuki Yamada
Hideyuki Yamada
We have reported that the protein-protein interaction between UDP-glucuronosyltransferase (UGT) 2B7 and cytochrome P450 3A4 (CYP3A4) alters UGT2B7 function. However, the domain(s) involved in the interaction are largely unknown. To address this issue, we examined in more detail the CYP3A4-UGT2B7 association by means of immunoprecipitation, overlay assay, and cross-linking involving 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide. Purified CYP3A4 or glutathione transferase (GST)-tagged CYP3A4 was cross-linked to UGT2B7 in solubilized baculosomes. The formation of the cross-linked complex was detected by immunoblotting using both antibodies against CYP3A4 and UGTs. Although the GST-tagged CYP3A4 containing the region ranging from Tyr25 to Ala503 was cross-linked to UGT2B7, the same did not occur when another construct containing Met145 to His267 was used. This observation was consistent with the result of the overlay assay indicating that CYP3A4 lacking the N-terminal hydrophobic segment retains the ability to associate with UGT2B7, whereas the Met145-to-His267 region loses this capacity. Although the Met145-to-His267 peptide was recognized by one anti-CYP3A4 antibody that has the ability to coimmunoprecipitate UGT2B7, it was not recognized by another antibody incapable of coimmunoprecipitating UGT2B7. The epitope of the latter antibody was mapped to the Leu331-to-Lys342 region, which is located on the J-helix of CYP3A4. Taken together, the results obtained suggest that 1) CYP3A4 and UGT2B7 are a pair of enzymes in proximity to each other and 2) either the Leu331-to-Lys342 domain or the surrounding region plays a role in the interaction with UGT2B7, whereas the hydrophobic Met145-to-His267 region does not contribute to this interaction.

1 December 2005 in Neuropharmacology
Verified
Journal Article
Closed access
TSTsutomu Suzuki
Tsutomu Suzuki
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
MOMasahiko Ozaki
Masahiko Ozaki
JKJunaidi Khotib
Junaidi Khotib
ANAtsushi Nakamura
Atsushi Nakamura
MNMinoru Narita
Minoru Narita

1 January 2010 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
YIYuji Ishii
Yuji Ishii
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
HYHideyuki Yamada
Hideyuki Yamada
Glucuronidation is one of the major pathways of metabolism of endo- and xenobiotics. UDP-Glucuronosyltransferase (UGT)-catalyzed glucuronidation accounts for up to 35% of phase II reactions. The expression and function of UGT is modulated by gene regulation, post-translational modifications and protein-protein association. Many studies have focused on drug-drug interactions involving UGT, and there are a number of reports describing the inhibition of UGT by xenobiotics. However, studies about the role of endogenous compounds as an inhibitor or activator of UGT are limited, and it is important to understand any change in the function and regulation of UGT by endogenous compounds. Recent studies in our laboratory have shown that fatty acyl-CoAs are endogenous activators of UGT, although fatty acyl-CoAs had been considered as inhibitors of UGT. Further, we have also suggested that adenine and related compounds are endogenous allosteric inhibitors of UGT. In this review, we summarize the endogenous modulators of UGT and discuss their relevance to UGT function.

17 December 2018 in Indonesian Journal of Pharmacy
Verified
Journal Article
Open access
PDF file
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
WWWirasti Wirasti
Wirasti Wirasti
ADArifin Dirman
Arifin Dirman
ELEndang Lukitaningsih
Endang Lukitaningsih
ARAdillah Rahmawati
Adillah Rahmawati
NFNanang Fakhrudin
Nanang Fakhrudin
Effects of Antioxidant, Anti-Collagenase, Anti-Elastase, Anti-Tyrosinase of The Extract and Fraction From Turbinaria decurrens Bory.

31 December 2022 in Journal of Herbmed Pharmacology
Verified
Journal Article
Open access
PDF file
AAAnggun Selvya Arsyad
Anggun Selvya Arsyad
Arief NurrochmadArief Nurrochmad
Arief Nurrochmad
NFNanang Fakhrudin
Nanang Fakhrudin
Ficus elastica Roxb. ex Hornem is usually found in tropical and subtropical areas, used in traditional medicine for various health problems, including pain, rheumatism, diarrhea, hypertension, infection, skin allergies, anemia, wound, hernia, and hemorrhoids. This review aims to present the phytoconstituents and pharmacological activities of F. elastica. A literature search employing PubMed, Google Scholar, Semantic Scholar, and Library was done to retrieve the relevant articles. F. elastica is a good source of traditional medicine for the treatment of various types of diseases, especially for microbial infections and preeclampsia. Quercitrin and myricetrin, having strong antioxidant activity, as well as ficusamide, ficusoside B, elastiquinone, elasticoside, and elasticamide are compounds, which have potential to be developed as new drugs for these conditions. In sum, the data regarding the pharmacological and safety aspects of this plant and its components are still limited. However, F. elastica is a natural product that has beneficial to human health and might be a good source for the preparation of new drugs.